Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity ...

But often the cancer will return and the entire bladder will be removed. “That comes like all kind of the side effects a ...

When interferon treatment was being developed in the Soviet Union, this was effectively overlooked in the West during the cold-war era due to its concentration on the development of vaccines.

Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, ...

Dr. Krishna said: "Interferon gamma can be used to treat ... Long COVID into subtypes which could be used to personalize treatment. "It's unlikely that all the different Long COVID symptoms ...

Sobi announces a new research collaboration on the development of Gamifant in sepsis, which is to be presented at the ISICEM congress: Stockholm Thursday, March 20, 2025, 12:00 Hr ...

Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding ...

Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk ...

Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according ...

The EMBRACE Phase 2a study will adopt a precision immunotherapy approach for the treatment of sepsis driven by the IDS ...

St. Jude researchers identified a protein, voltage-dependent anion channel 2 (VDAC2), that tumors use as a “signal jammer” to prevent cancer cell death and evade the immune system’s functioning.